+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type, Treatment Type, Distribution Channel, and Country: Trend Forecast and Growth Opportunity

  • ID: 5582307
  • Report
  • April 2022
  • Region: Europe
  • 94 Pages
  • GMD Research

FEATURED COMPANIES

  • Bayer AG
  • Cipla Ltd
  • Galderma SA
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Lumenis Ltd
North America onychomycosis treatment market is projected to grow by 7.2% annually in the forecast period and reach $2,111.2 million by 2031, driven by the increasing prevalence of chronic medical ailments, the growing geriatric population, improved therapies and preventative solutions, and the rising healthcare expenditure.



Highlighted with 21 tables and 36 figures, this 87-page report “North America Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Others), Treatment Type (Drug Treatment, Laser Therapy, Photodynamic Therapy, Others), Distribution Channel (Hospitals and Clinics, Online Stores, Retail Pharmacies, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America onychomycosis treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Five Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and the Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America onychomycosis treatment market in every aspect of the classification from perspectives of Onychomycosis Type, Treatment Type, Distribution Channel, and Country.

Based on Onychomycosis Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Distal Subungual Onychomycosis
  • White Superficial Onychomycosis
  • Proximal Subungual Onychomycosis
  • Candidal Onychomycosis
  • Other Onychomycosis Types

Based on Treatment Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Drug Treatment
  • Laser Therapy
  • Photodynamic Therapy
  • Other Therapies

By Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Hospitals and Clinics
  • Online Stores
  • Retail Pharmacies
  • Other Distribution Channels

Geographically, the following national/local markets are fully investigated:

  • U.S.
  • Canada
  • Mexico

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Onychomycosis Type, Treatment Type and Distribution Channel over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

  • Bausch Health Companies Inc.
  • Bayer AG
  • Cipla Ltd
  • Dr. Reddys Laboratories Ltd
  • Galderma SA
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Lumenis Ltd
  • Medimetriks Pharmaceuticals Inc.
  • Moberg Pharma AB
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
Frequently Asked Questions about the European Onychomycosis Treatment Market

What is the estimated value of the European Onychomycosis Treatment Market?

The European Onychomycosis Treatment Market was estimated to be valued at $729.0 Million in 2021.

What is the growth rate of the European Onychomycosis Treatment Market?

The growth rate of the European Onychomycosis Treatment Market is 7.6%, with an estimated value of $1518.0 Million by 2031.

What is the forecasted size of the European Onychomycosis Treatment Market?

The European Onychomycosis Treatment Market is estimated to be worth $1518.0 Million by 2031.

Who are the key companies in the European Onychomycosis Treatment Market?

Key companies in the European Onychomycosis Treatment Market include Bausch Health Companies Inc., Bayer AG, Cipla Ltd, Dr. Reddys Laboratories Ltd, Galderma SA, GlaxoSmithKline PLC, Johnson & Johnson, Lumenis Ltd and Moberg Pharma AB.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer AG
  • Cipla Ltd
  • Galderma SA
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Lumenis Ltd

1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis
3 Segmentation of North America Market by Onychomycosis Type
3.1 Market Overview by Onychomycosis Type
3.2 Distal Subungual Onychomycosis
3.3 White Superficial Onychomycosis
3.4 Proximal Subungual Onychomycosis
3.5 Candidal Onychomycosis
3.6 Other Onychomycosis Types
4 Segmentation of North America Market by Treatment Type
4.1 Market Overview by Treatment Type
4.2 Drug Treatment
4.3 Laser Therapy
4.4 Photodynamic Therapy
4.5 Other Therapies
5 Segmentation of North America Market by Distribution Channel
5.1 Market Overview by Distribution Channel
5.2 Hospitals and Clinics
5.3 Online Stores
5.4 Retail Pharmacies
5.5 Other Distribution Channels
6 North America Market 2021-2031 by Country
6.1 Overview of North America Market
6.2 U.S.
6.3 Canada
6.4 Mexico
7 Competitive Landscape
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cipla Ltd
  • Dr. Reddys Laboratories Ltd
  • Galderma SA
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Lumenis Ltd
  • Medimetriks Pharmaceuticals Inc.
  • Moberg Pharma AB
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA

List of Tables

Table 1. Snapshot of North America Onychomycosis Treatment Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. Clinical Trials of Onychomycosis Treatment
Table 4. World Health Spending by Region, $ bn, 2013-2020
Table 5. Main Product Trends and Market Opportunities in North America Onychomycosis Treatment Market
Table 6. North America Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn
Table 7. North America Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn
Table 8. North America Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn
Table 9. North America Onychomycosis Treatment Market by Country, 2021-2031, $ mn
Table 10. U.S. Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn
Table 11. U.S. Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn
Table 12. U.S. Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn
Table 13. Canada Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn
Table 14. Canada Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn
Table 15. Canada Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn
Table 16. Mexico Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn
Table 17. Mexico Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn
Table 18. Mexico Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn
Table 19. Bausch Health Companies Inc.: Company Snapshot
Table 20. Bausch Health Companies Inc.: Business Segmentation
Table 21. Bausch Health Companies Inc.: Product Portfolio

List of Figures

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. North America Onychomycosis Treatment Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of North America Onychomycosis Treatment Market
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060
Figure 9. Primary Restraints and Impact Factors of North America Onychomycosis Treatment Market
Figure 10. Investment Opportunity Analysis
Figure 11. Porter’s Five Forces Analysis of North America Onychomycosis Treatment Market
Figure 12. Breakdown of North America Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, % of Revenue
Figure 13. North America Addressable Market Cap in 2022-2031 by Onychomycosis Type, Value ($ mn) and Share (%)
Figure 14. North America Onychomycosis Treatment Market by Onychomycosis Type: Distal Subungual Onychomycosis, 2021-2031, $ mn
Figure 15. North America Onychomycosis Treatment Market by Onychomycosis Type: White Superficial Onychomycosis, 2021-2031, $ mn
Figure 16. North America Onychomycosis Treatment Market by Onychomycosis Type: Proximal Subungual Onychomycosis, 2021-2031, $ mn
Figure 17. North America Onychomycosis Treatment Market by Onychomycosis Type: Candidal Onychomycosis, 2021-2031, $ mn
Figure 18. North America Onychomycosis Treatment Market by Onychomycosis Type: Other Onychomycosis Types, 2021-2031, $ mn
Figure 19. Breakdown of North America Onychomycosis Treatment Market by Treatment Type, 2021-2031, % of Sales Revenue
Figure 20. North America Addressable Market Cap in 2022-2031 by Treatment Type, Value ($ mn) and Share (%)
Figure 21. North America Onychomycosis Treatment Market by Treatment Type: Drug Treatment, 2021-2031, $ mn
Figure 22. North America Onychomycosis Treatment Market by Treatment Type: Laser Therapy, 2021-2031, $ mn
Figure 23. North America Onychomycosis Treatment Market by Treatment Type: Photodynamic Therapy, 2021-2031, $ mn
Figure 24. North America Onychomycosis Treatment Market by Treatment Type: Other Therapies, 2021-2031, $ mn
Figure 25. Breakdown of North America Onychomycosis Treatment Market by Distribution Channel, 2021-2031, % of Sales Revenue
Figure 26. North America Addressable Market Cap in 2022-2031 by Distribution Channel, Value ($ mn) and Share (%)
Figure 27. North America Onychomycosis Treatment Market by Distribution Channel: Hospitals and Clinics, 2021-2031, $ mn
Figure 28. North America Onychomycosis Treatment Market by Distribution Channel: Online Stores, 2021-2031, $ mn
Figure 29. North America Onychomycosis Treatment Market by Distribution Channel: Retail Pharmacies, 2021-2031, $ mn
Figure 30. North America Onychomycosis Treatment Market by Distribution Channel: Other Distribution Channels, 2021-2031, $ mn
Figure 31. Breakdown of North America Onychomycosis Treatment Market by Country, 2021 and 2031, % of Revenue
Figure 32. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 33. U.S. Onychomycosis Treatment Market, 2021-2031, $ mn
Figure 34. Canada Onychomycosis Treatment Market, 2021-2031, $ mn
Figure 35. Onychomycosis Treatment Market in Mexico, 2021-2031, $ mn
Figure 36. Growth Stage of North America Onychomycosis Treatment Industry over the Forecast Period
Note: Product cover images may vary from those shown
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cipla Ltd
  • Dr. Reddys Laboratories Ltd
  • Galderma SA
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Lumenis Ltd
  • Medimetriks Pharmaceuticals Inc.
  • Moberg Pharma AB
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
Note: Product cover images may vary from those shown

Loading
LOADING...